Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole and Testosterone in Men With Epilepsy and Hypogonadism
NCT00179517Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jun 2001
- Primary completion
- Apr 2008
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sexual dysfunction and Hypogonadism comparing Depotestosterone + Anastrozole with Depotestosterone + Placebo (2 arms). Primary endpoint: Sexual Function Scores (S-Score and Reynolds' Sexual Questionnaires) at 3 months. Started Jun 2001; status: completed.
02
Drugs
anastrozole
03
Conditions
sexual dysfunctionHypogonadism
Beyond the preview
Go deeper on NCT00179517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179517.